Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Study to Measure and Enhance the Health Related Quality Of Life in Cancer Patients Receiving Immune Checkpoint Modulators

NCT05248425 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT05248425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05248425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Study to Measure and Enhance the Health Related Quality Of Life in Cancer Patients Receiving Immune Checkpoint Modulators
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Withdrawn
Start date
January 31, 2023
Completion date
October 31, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer